BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 18632656)

  • 1. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.
    Ji Y; Olson J; Zhang J; Hildebrandt M; Wang L; Ingle J; Fredericksen Z; Sellers T; Miller W; Dixon JM; Brauch H; Eichelbaum M; Justenhoven C; Hamann U; Ko Y; Brüning T; Chang-Claude J; Wang-Gohrke S; Schaid D; Weinshilboum R
    Cancer Res; 2008 Jul; 68(14):5997-6005. PubMed ID: 18632656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catechol-O-methyltransferase Val 108/158 Met polymorphism in premenopausal breast cancer patients.
    Sazci A; Ergul E; Utkan NZ; Canturk NZ; Kaya G
    Toxicology; 2004 Nov; 204(2-3):197-202. PubMed ID: 15388245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.
    Thompson PA; Shields PG; Freudenheim JL; Stone A; Vena JE; Marshall JR; Graham S; Laughlin R; Nemoto T; Kadlubar FF; Ambrosone CB
    Cancer Res; 1998 May; 58(10):2107-10. PubMed ID: 9605753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.
    Gaudet MM; Chanock S; Lissowska J; Berndt SI; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Garcia-Closas M
    Cancer Res; 2006 Oct; 66(19):9781-5. PubMed ID: 17018638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.
    Gaudet MM; Bensen JT; Schroeder J; Olshan AF; Terry MB; Eng SM; Teitelbaum SL; Britton JA; Lehman TA; Neugut AI; Ambrosone CB; Santella RM; Gammon MD
    Breast Cancer Res Treat; 2006 Sep; 99(2):235-40. PubMed ID: 16596327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic catechol-O-methyltransferase gene, soy isoflavone intake and breast cancer in postmenopausal women: a case-control study.
    Wang Q; Wang YP; Li JY; Yuan P; Yang F; Li H
    Chin J Cancer; 2010 Jul; 29(7):683-8. PubMed ID: 20591221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
    Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
    Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
    Lin WY; Chou YC; Wu MH; Jeng YL; Huang HB; You SL; Chu TY; Chen CJ; Sun CA
    Cancer Detect Prev; 2005; 29(5):427-32. PubMed ID: 16191465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MB-COMT polymorphisms with schizophrenia-susceptibility and symptom severity in an African cohort.
    Wright GE; Niehaus DJ; van der Merwe L; Koen L; Korkie LJ; Kinnear CJ; Drögemöller BI; Warnich L
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):163-9. PubMed ID: 22705295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
    Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
    Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
    Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Kang D; Vainio H; Uusitupa M; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):635-40. PubMed ID: 11401913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.
    Okochi T; Ikeda M; Kishi T; Kawashima K; Kinoshita Y; Kitajima T; Yamanouchi Y; Tomita M; Inada T; Ozaki N; Iwata N
    Schizophr Res; 2009 May; 110(1-3):140-8. PubMed ID: 19329282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytochrome P450 CYP1B1 and catechol O-methyltransferase (COMT) genetic polymorphisms and breast cancer susceptibility in a Turkish population.
    Kocabaş NA; Sardaş S; Cholerton S; Daly AK; Karakaya AE
    Arch Toxicol; 2002 Nov; 76(11):643-9. PubMed ID: 12415427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catechol-O-methyltransferase Val 108/158 Met polymorphism and breast cancer risk: a case control study in Syria.
    Lajin B; Hamzeh AR; Ghabreau L; Mohamed A; Al Moustafa AE; Alachkar A
    Breast Cancer; 2013 Jan; 20(1):62-6. PubMed ID: 22124994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol O-methyltransferase pharmacogenomics: human liver genotype-phenotype correlation and proximal promoter studies.
    Zhang J; Ji Y; Moon I; Pelleymounter LL; Ezequel Salavaggione O; Wu Y; Jenkins GD; Batzler AJ; Schaid DJ; Weinshilboum RM
    Pharmacogenet Genomics; 2009 Aug; 19(8):577-87. PubMed ID: 19641441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha, COMT and CYP19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.
    Hu Z; Song CG; Lu JS; Luo JM; Shen ZZ; Huang W; Shao ZM
    J Cancer Res Clin Oncol; 2007 Dec; 133(12):969-78. PubMed ID: 17562079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catechol-O-methyltransferase gene polymorphism and post-menopausal breast cancer risk.
    Wedrén S; Rudqvist TR; Granath F; Weiderpass E; Ingelman-Sundberg M; Persson I; Magnusson C
    Carcinogenesis; 2003 Apr; 24(4):681-7. PubMed ID: 12727796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential role of membrane-bound COMT gene polymorphisms in female depression vulnerability.
    Hatzimanolis A; Vitoratou S; Mandelli L; Vaiopoulos C; Nearchou FA; Stefanis CN; Serretti A; Stefanis NC
    J Affect Disord; 2013 Jun; 148(2-3):316-22. PubMed ID: 23351565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.